In vivo pharmacodynamics of antifungal drugs in treatment of candidiasisANDES, David.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 4, pp 1179-1186, issn 0066-4804, 8 p.Article

Optimizing antifungal choice and administrationANDES, David.Current medical research and opinion. 2013, Vol 29, pp 13-18, issn 0300-7995, 6 p., SUP4Article

Candida albicans biofilm development, modeling a host-pathogen interactionNETT, Jeniel; ANDES, David.Current opinion in microbiology. 2006, Vol 9, Num 4, pp 340-345, issn 1369-5274, 6 p.Article

Antifungal therapy: current concepts and evidence-based managementPERFECT, John R; ANDES, David.Current medical research and opinion. 2013, Vol 29, issn 0300-7995, 17 p., SUP4Serial Issue

In vivo pharmacodynamic activity of the glycopeptide dalbavancinANDES, David; CRAIG, William A.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 5, pp 1633-1642, issn 0066-4804, 10 p.Article

Antifungal Therapeutic Drug Monitoring : Established and Emerging IndicationsANDES, David; PASCUAL, Andres; MARCHETTI, Oscar et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 1, pp 24-34, issn 0066-4804, 11 p.Article

Synergistic Effect of Calcineurin Inhibitors and Fluconazole against Candida albicans BiofilmsUPPULURI, Priya; NETT, Jeniel; HEITMAN, Joseph et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 3, pp 1127-1132, issn 0066-4804, 6 p.Article

Primary cutaneous cryptococcosis in immunocompetent and immunocompromised hosts: Parts of this report were presented at the 40th annual meeting of the IDSA; 24-27 October 2002, Chicago, IL; Poster no. 375CHRISTIANSON, John C; ENGBER, William; ANDES, David et al.Medical mycology (Oxford. Print). 2003, Vol 41, Num 3, pp 177-188, issn 1369-3786, 12 p.Article

Fungal diagnosis: how do we do it and can we do better?PERFECT, John R.Current medical research and opinion. 2013, Vol 29, pp 3-11, issn 0300-7995, 9 p., SUP4Article

In vivo pharmacodynamic activity of daptomycinSAFDAR, Nasia; ANDES, David; CRAIG, W. A et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 1, pp 63-68, issn 0066-4804, 6 p.Article

Therapeutic Drug Monitoring of Antifungals : Pharmacokinetic and Pharmacodynamic ConsiderationsSMITH, Jeannina; ANDES, David.Therapeutic drug monitoring. 2008, Vol 30, Num 2, pp 167-172, issn 0163-4356, 6 p.Article

β-1,3 Glucan as a test for central venous catheter biofilm infectionNETT, Jeniel; LINCOLN, Leslie; MARCHILLO, Karen et al.The Journal of infectious diseases. 2007, Vol 195, Num 11, pp 1705-1712, issn 0022-1899, 8 p.Article

Histoplasmosis After Solid Organ TransplantASSI, Maha; MARTIN, Stanley; YOUNG, Jo-Anne H et al.Clinical infectious diseases. 2013, Vol 57, Num 11, pp 1542-1549, issn 1058-4838, 8 p.Article

Impact of In Vivo Triazole and Echinocandin Combination Therapy for Invasive Pulmonary Aspergillosis: Enhanced Efficacy against Cyp51 Mutant IsolatesLEPAK, Alexander J; MARCHILLO, Karen; VANHECKER, Jamie et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 11, pp 5438-5447, issn 0066-4804, 10 p.Article

Optimizing Echinocandin Dosing and Susceptibility Breakpoint Determination via In Vivo Pharmacodynamic Evaluation against Candida glabrata with and without fks MutationsLEPAK, Alexander; CASTANHEIRA, Mariana; DIEKEMA, Daniel et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 11, pp 5875-5882, issn 0066-4804, 8 p.Article

Role of Fkslp and Matrix Glucan in Candida albicans Biofilm Resistance to an Echinocandin, Pyrimidine, and PolyeneNETT, Jeniel E; CRAWFORD, Kyler; MARCHILLO, Karen et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 8, pp 3505-3508, issn 0066-4804, 4 p.Article

Posaconazole Pharmacodynamic Target Determination against Wild-Type and Cyp51 Mutant Isolates of Aspergillus fumigatus in an In Vivo Model of Invasive Pulmonary AspergillosisLEPAK, Alexander J; MARCHILLO, Karen; VANHECKER, Jaimie et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 1, pp 579-585, issn 0066-4804, 7 p.Article

Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activityADAMS, Monica L; ANDES, David R; KWON, Glen S et al.Biomacromolecules. 2003, Vol 4, Num 3, pp 750-757, issn 1525-7797, 8 p.Article

Combination Antifungal Therapy Involving Amphotericin B, Rapamycin and 5-Fluorocytosine Using PEG-Phospholipid Micelles : Polymeric micelles for drug deliveryVAKIL, Ronak; KNILANS, Kayla; ANDES, David et al.Pharmaceutical research. 2008, Vol 25, Num 9, pp 2056-2064, issn 0724-8741, 9 p.Article

Isavuconazole (BAL4815) Pharmacodynamic Target Determination in an In Vivo Murine Model of Invasive Pulmonary Aspergillosis against Wild-Type and cyp51 Mutant Isolates of Aspergillus fumigatusLEPAK, Alexander J; MARCHILLO, Karen; VANHECKER, Jamie et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 12, pp 6284-6289, issn 0066-4804, 6 p.Article

Addition of Ceftaroline to Daptomycin after Emergence of Daptomycin-Nonsusceptible Staphylococcus aureus during Therapy Improves Antibacterial ActivityROSE, Warren E; SCHULZ, Lucas T; ANDES, David et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 10, pp 5296-5302, issn 0066-4804, 7 p.Article

Protein Binding: Do We Ever Learn?ZEITLINGER, Markus A; DERENDORF, Hartmut; MOUTON, Johan W et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 7, pp 3067-3074, issn 0066-4804, 8 p.Article

Clinical Practice Guidelines for the Management of Candidiasis : 2009 Update by the Infectious Diseases Society of AmericaPAPPAS, Peter G; KAUFFMAN, Carol A; REBOLI, Annette C et al.Clinical infectious diseases. 2009, Vol 48, Num 5, pp 503-535, issn 1058-4838, 33 p.Article

Safety and Outcomes of Open-Label Deferasirox Iron Chelation Therapy for MucormycosisSPELLBERG, Brad; ANDES, David; PEREZ, Mario et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 7, pp 3122-3125, issn 0066-4804, 4 p.Article

Voriconazole Use for Endemic Fungal Infections 7FREIFELD, Alison; PROIA, Laurie; ANDES, David et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 4, pp 1648-1651, issn 0066-4804, 4 p.Article